EcoDrugPlus

Histone Deacetylase 1

Ensembl ID : ENSIPUG00000014455
Gene Symbol: HDAC1
4 Cross references
309 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSIPUG00000013207
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSIPUG00000013866
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSIPUG00000001578
Gene Symbol: HDAC2
3 Cross references
209 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSIPUG00000013646
Gene Symbol: HDAC3
3 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSIPUG00000021921
Gene Symbol: LOC108271830
2 Cross references
195 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSIPUG00000008109
Gene Symbol: HDAC4
2 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSIPUG00000009003
Gene Symbol: HDAC5
3 Cross references
196 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSIPUG00000013277
Gene Symbol: HDAC6
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 7a

Ensembl ID : ENSIPUG00000017353
Gene Symbol: HDAC7A
2 Cross references
189 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSIPUG00000000898
Gene Symbol: HDAC8
3 Cross references
205 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSIPUG00000010745
Gene Symbol: HCN4
3 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).